Understanding Parkinsonism: The Clinical Perspective Amit Batla, Deepti Vibha
INDEX
Page numbers followed by f refer to figure, b refer to box, and t refer to table
A
Acetylcholinesterase inhibitor 65, 159, 251
Acquired hepatolenticular degeneration 2
Ageusia 148
Akinesia 15
Akinetic rigid phenotype 94b
Alzheimer's disease 23, 228, 230, 232234, 241, 243, 247, 249252, 260
Amantadine 151, 169
Amino acids 46
Amitriptyline 64
Amyotrophic lateral sclerosis 46, 213, 249, 264
Anal sphincter electromyography 122
Anemia, hemolytic 293
Anhedonia 148t
Antidepressants 64
Antihypertensives 65
Antimuscarinics 77
Antiphospholipid antibody syndrome 262
Antipsychotic drugs 2
Anxiety 5, 95, 104, 148, 231, 236
Apla syndrome 267
Argyrophilic grain disease 241
Aromatic amino acid decarboxylase 132
Ataxia syndrome 258
Autologous mesenchymal stem cells 215
Autonomic dysfunction 60, 70, 70t, 94, 122, 157, 178, 191, 231
in Parkinson's disease 70
bowel dysfunction 70,73
cardiovascular dysfunction 70,71
lower urinary tract dysfunction 71,75
sexual dysfunction 71,78
Autonomic nervous system 73
B
Bacterial
infections 284
meningitis 287
Basal ganglia 2, 133f, 137f, 296
calcification 275
Bell's phenomenon 121
Benserazide 151
Benzodiazepines 64
Bladder
disturbances 148
dysfunction 65
Blepharospasm 188
Blink reflex 122, 126
recovery curve 126
Borrelia 285
Botulinum
neurotoxin 188, 192
toxin
injections 77
role of 187
Bradykinesia 3, 8, 10, 11, 15, 50, 118, 146, 164, 228
Brain
calcification, deposition of 273f
iron accumulation 2
Bright light therapy 64
Bulbar dysfunction 211
C
Camptocormia 4, 190
Carbidopa 151
Carbon monoxide 2
Cardiac metaiodobenzylguanidine 212
Carotid vessel occlusion 263
Catechol-O-methyltransferase 168
inhibitor 167, 169, 170
Central motor conduction time 124
Central nervous system 78, 272, 279
infections 279
Cerebellar
ataxia 6, 208
tremor 8
Cerebral
autosomal dominant arteriopathy 249
calcification, causes of 276t
Cerebrospinal fluid 234, 248, 275, 279
testing 275
Cerebrotendinous xanthomatosis 258, 262, 267
Cerebrovascular disease 241
Cervical dystonia 188
Chaperone-mediated autophagy 50
Chikungunya 283
Chorea 284, 287
Clonazepam 64
Clonidine 73
Clozapine 65, 97
Cognitive dysfunction 148, 158
pattern of 98
Color vision 62, 148
Confusion 148
Coronavirus 36t
Cortical
atrophy, posterior 242, 247
myoclonus 127
Corticobasal
degeneration 2, 3, 44, 123, 208, 221, 240, 241, 247, 261
pathology 242t
ganglionic degeneration 134, 139
syndrome 12, 100, 123, 125, 127, 139f, 222, 240242, 245, 249, 256, 260, 261, 267
Cranial nerves 12
Creutzfeldt-Jakob disease 241, 261, 265, 267
Crude prevalence rate 25
Cyanide 2
D
Deep brain stimulation 167, 170, 172
Dehydration 65
Delirium 62
Delusions 96
Dementia 3, 5, 6, 12, 15, 53, 65, 96, 101, 102, 148, 176, 227229
treatment of 103
Depression 5, 15, 64, 94, 95, 97, 104, 111, 148, 175
Desipramine 64
Diabetes mellitus 71
Domperidone 65
Donepezil 65t, 103
Dopamine 170
transporter 132, 139, 212, 233
Dysarthria 6, 9, 15, 293
Dysautonomia 63,70,71t
advanced 72
cardiovascular 73t
symptomatic 10b
Dyskinesias 4, 84, 170
types of 171
Dysphagia 15, 148, 180
Dystonia 4, 188, 192, 287
lower limb 189
upper limb 189
E
Eating disorders 95
Electroencephalography 118, 127, 284
Electromyography 118, 126
Encephalitis 282
Ephedrine 65
Erectile dysfunction 62, 64, 71, 78, 148, 179
Ethopropazine 170
Excessive daytime
sleepiness 62, 64, 87, 157, 169
somnolence 83, 86, 148, 179
Extrapyramidal syndrome 293
F
Fahr's disease 270272, 272t, 273f, 274, 275, 277
Fatigue 62, 64, 119, 148, 160
Fecal incontinence 148
Fiber-rich diet 65
Fibroblast growth factor 48
Fluctuation 284
Focal dystonia 189
Folic acid 36
Foot dystonia 4
Fragile X syndrome 256
Frontal behavioral-spatial syndrome 248
Frontotemporal
dementia 49, 222, 242, 244, 246, 249
lobar degeneration 242, 252, 260, 261, 263
G
Gait 12
analysis 126
disturbance 15
Galantamine 103
Gastrointestinal tract 73
Gaucher's disease 109, 262, 265, 267
Genetic testing 234, 275
Genitourinary symptoms 156
Glucocerebrosidase 51, 59
Gluten ataxia 259
Guanosine triphosphatase 48
H
Haemophilus influenzae 285
Hallucinations 169
Haloperidol 2
Hemifacial spasm 287
Herpes simplex
encephalitis 279, 283f, 287
virus 282
Hoffmann's reflex 120, 126
Huntington's disease 258
Hydroxydopamine 61
Hyperhidrosis 192
Hyperparathyroidism 276
Hypersalivation 293
Hypertension 36
portal 294
Hypokinesia 119
Hypoparathyroidism 2, 275, 276
Hyposmia 110
late-onset 62
Hypotension 65
orthostatic 65, 70, 71, 148, 169, 213
postprandial 70, 71
postural 64
Hypoxic ischemic injury 296
Hysterectomy 37
I
Insomnia 64, 148, 179
International Index of Erectile Function 79
International Parkinson's Disease Genomics Consortium 47
Intrapenile prosthesis 79
Japanese encephalitis 36, 279, 281, 282, 283f, 296
K
Kayser-Fleischer ring 289, 293, 294f
L
Lactulose 65
Legionella 285
Leigh's disease 296
Leprosy 286
Leukoencephalopathy 249
Levodopa 150, 151
carbidopa
combination 103
intestinal gel 167, 170, 173
induced psychosis 96
Lewy body 2, 3, 6, 12, 44, 92, 96, 100, 101, 103, 110, 180, 208, 227229, 232, 232f, 234f
diseases 213
Lid apraxia 188, 192
Lithium 2
Liver
biopsy 296
cirrhosis 294
disease 293
dysfunction 293
function tests, abnormal 293
transplant 298
Lower urinary tract 70
dysfunction 71, 75, 77t
symptoms 75
Lubiprostone 65
M
Malaria 286, 287
Mania 95b
Melatonin 64
Memantine 65
Metaiodobenzylguanidine 72, 140, 233
Methane 2
Methylphenidate 64
Middle cerebellar peduncle 257
Minipolymyoclonus 123
Mitochondria 52
Mitochondrial
dysfunction 23, 51
mutations 265
Modafinil 64
Monoamine oxidase 149
inhibitors 150, 165, 167, 169, 170
Mood disorder 59, 158
Motor
fluctuations 165, 167t
manifestations 228
system 12
Movement disorders 279, 284, 286
mechanism of 280
mixed 293
pathophysiology of 282
Multifocal leukoencephalopathy, progressive 262, 267
Multi-infarct state 2b
Multiple system atrophy 2, 3, 6, 12, 44, 71, 92, 97, 100, 110, 122, 125, 127, 133, 134, 139, 147, 156, 175, 207, 216, 223, 230, 256, 257
Muscle tone 120
Mutation, types of 43
Mycoplasma 285
Myoclonus 123, 287
N
Neisseria meningitidis 285
Neurocysticercosis 286, 287
Neurological disorders 10
Neuronal ceroid lipofuscinosis 51
Neurosyphilis 2, 262, 266, 267, 285, 287
Nocardia asteroides 36
Nocturia 65, 71, 76t, 84, 87, 148
Nocturnal polyuria 76
Nonmotor fluctuations 63, 148, 167
Nonsteroidal anti-inflammatory drug 37
Normal pressure hydrocephalus 2, 6, 258t
Normalized cerebellar metabolism 234
Nortriptyline 64
O
Obsessive-compulsive disorder 284
Obstructive sleep apnea 83, 85
Oligodendroglial cytoplasmic inclusions 207
Olivopontocerebellar atrophy 208, 242, 247
Opsoclonus-myoclonus syndrome 287
Oral atropine drops 64
Orofacial dyskinesia 281
Oromandibular involvement 293
Orthostasis 177
Oxidative stress 23
Oxybutynin 65
P
Pain 62, 65, 66, 148, 160
Panic attacks 148
Paraneoplastic syndrome 260
Paraphilias 95
Parasitic infections 286
Paraventricular nucleus 78
Pardoprunox 150
Paresthesia 148
Parkinson's disease 117, 2325, 29, 3134, 36t, 37, 42, 43t, 4451, 53, 54, 5861, 63, 66, 67, 70, 70t, 7173, 73t, 7476, 76t–78t, 80, 8387, 88t, 89, 9496, 98, 99, 101, 102, 108113, 117121, 124126, 130, 131, 145, 146, 146t, 147149, 151t, 152, 154160, 164166, 166t, 169t, 170, 172, 173, 175, 177, 179, 180, 187, 188, 191, 192, 223, 227229, 234, 259, 281
disease burden of 32t
early-onset 167, 170
idiopathic 3, 131, 133f–135f, 139, 140, 188, 208
late-onset 165
later stages of 175
management of 187
nonmotor symptoms of 61, 148t
prevalence of 25, 26t
prodromal 107
treatment of 17
Pediatric autoimmune neuropsychiatric disorders 284, 287
Penicillamine 297
Percutaneous tibial nerve stimulation 77
Periodic limb movements 148
Perry syndrome 264
Phosphodiesterase-5 inhibitors 64
Pick's disease 246
Pisa syndrome 211
Polysomnography 214
Postsynaptic dopaminergic radiotracers 133
Pramipexole 64, 151
Premature ejaculation 71, 78
Presynaptic dopaminergic radiotracers 132
Primary familial brain calcification 271
Primary progressive aphasia 242, 244, 246
Protein aggregation 50
Pseudohypoparathyroidism 276
Psychiatric disorders, spectrum of 93
Psychosis 5, 9597, 104, 169, 175
Pyridostigmine 73
Q
Quetiapine 65, 98, 103
R
Randomized controlled trials 150, 154
Rapid eye movement 59, 60, 62, 66, 83, 87, 89f, 95, 96, 176, 180, 207, 231
Reflux 148
Restless legs syndrome 83, 87, 88t, 242, 245
Risperidone 103
Rivastigmine 103
Ropinirole 151
S
Safinamide 150
Saliva, dribbling of 64, 148
Salmonella 285
Schizophrenia 97
Sclerosing panencephalitis, subacute 284
Seborrheic dermatitis 178
Selective noradrenalin reuptake inhibitors. 66
Selective serotonin reuptake inhibitors 64, 66, 175
Septic meningitis 285
Sexual
disorders 95
dysfunction 71, 78, 78t
Sialorrhea 178, 190, 192
Sildenafil 64, 79
Single-joint ballistic movements 126
Sleep
behavior disorder 60, 62, 64, 83, 87, 89f, 94, 96, 107, 148, 157, 180, 207, 231
disorders 62, 95, 148, 231
disturbances 83, 94
domain 157
dysfunction 179
Sodium
chloride supplementation of meal 65
oxybate 64
valproate 2
Somatosensory evoked potentials 118, 127
Spastic paraplegia 258
Speech, apraxia of 245
Sphincter electromyography 212
Spinocerebellar ataxias 208, 257, 258
Sporadic adult-onset ataxia 208
Streptococcal infection 284, 287
Streptococcus pneumoniae 285
Striatonigral degeneration 208
Striopallidodentate calcinosis, bilateral 271
Stroke 2
Sublingual apomorphine 79
Substance abuse 95
Substantia nigra 46
pars compacta 281
pars reticulata 280
Subthalamic nucleus 124, 136, 170, 280
Sudomotor skin test 127
Supine hypertension 70, 71
Supranuclear palsy 2, 3, 12, 44, 92, 97, 100, 103, 121, 125, 126, 134, 138f, 139, 208, 219, 220, 224, 241, 242, 243f, 252, 256, 258t, 263
Sydenham's chorea 284, 287
Synaptosomal-associated protein 48
T
Tadalafil 79
Tetrabenazinbe 2
Tetrathiomolybdate 297
Thrombocytopenia 293
Tic disorder 284, 285
Tourette syndrome 285
Tremor 7, 15, 117
Treponema pallidum 285
Tricyclic antidepressant 64
Trihexyphenidyl 170
Tropheryma whipplei 286
Tubercular meningitis 285
U
Ubiquitin-proteasome system 50
Unified Parkinson's disease rating scale 63
Urinary dysfunction 177
V
Vacuum constriction devices 79
Vardenafil 79
Vesicular monoamine transporter 139
Video-oculography 121, 126
Visual dysfunction 94, 148
W
Whipple's disease 266, 286, 287
Wilson's disease 2, 289291, 292t, 293, 294, 295t, 296299
Z
Zinc 297, 298
Zopliclone 64
×
Chapter Notes

Save Clear


What Is and What Is Not Parkinson's Disease?CHAPTER 1

Amit Batla
 
INTRODUCTION
Parkinson's disease is characterized by tremor at rest, bradykinesia, rigidity, loss of postural reflexes, and gait problems. James Parkinson was accredited for his original well-recorded description of Parkinson's disease which is still quite correct despite advancement of understanding over the last two centuries. The historical aspects are well-discussed in chapter, “History of Parkinson's Disease: From Ancient Times to James Parkinson and Beyond”.
Parkinson's disease is not just a clinical syndrome but a pathological diagnosis that links the clinical symptoms and signs to the characteristic pathological findings on brain autopsy showing loss of pigmented dopaminergic neurons in the substantia nigra. The term “Parkinsonism” is used to describe the clinical syndrome that has close resemblance to the hallmarks of Parkinson's disease like bradykinesia, rigidity, and postural instability but have different underlying disease pathology. The etiology 2of parkinsonism can be neurodegenerative as in Parkinson's disease or atypical Parkinsonism (also called Parkinson plus syndromes) or may be a result of strokes (vascular parkinsonism), drugs (such as haloperidol or valproate), infections or encephalitis (postencephalitic), etc. (Flowchart 1 and Box 1). Parkinsonism can sometimes be an additional or even presenting clinical feature in other movement disorders such as Huntington's disease, spinocerebellar ataxias, dystonia Parkinsonism. Parkinsonian features may also be seen in metabolic defects that manifest with multiple neurological features and movement disorders (e.g., Wilson's disease, neurodegeneration with brain iron accumulation, etc).
Typically, Parkinson's disease responds well to medical therapy with dopaminergic drugs, at least in early years after diagnosis. However, the atypical Parkinsonism like multiple system atrophy (MSA) (see chapter on multiple system atrophy), progressive supranuclear palsy (PSP) (see chapter on clinical approach to progressive supranuclear palsy), dementia with Lewy bodies (DLB) (see chapter on dementia with lewy body disease), and corticobasal degeneration (CBD) (see chapter on corticobasal degeneration), have limited or no response to standard dopaminergic therapy, that is usually quite effective in Parkinson's disease. The patients with atypical Parkinsonian disorders have very limited survival and have very poor quality of life after diagnosis, and the management mainly relies on rehabilitative strategies.
zoom view
FLOWCHART 1: What is and what is not Parkinson's diseaseNBIA, neurodegeneration with brain iron accumulation; SCA, spinocerebellar ataxia.
TABLE 1   Classification of Parkinsonism based on the abnormal proteins—tau and synuclein
Tauopathies
Synucleinopathies
  • Progressive supranuclear palsy
  • Corticobasal degeneration
  • Guadelopean parkinsonian disorder
  • Frontemporal dementias with parkinsonism linked to chromosome 17 (FTDP 17)
  • Lewy body diseases
    • Idiopathic parkinson's disease and inherited lewy body diseases (PARK1,2,3,5,7,DJ-1)
    • Dementia with lewy bodies
    • Pure autonomic failure
  • Multiple system atrophy
3
The pathologies in degenerative Parkinsonism are classified into synucleinopathies and tauopathies depending on the underlying protein abnormality in either the α-synuclein or tau (summarized in table 1). The pathophysiological features of Parkinson's disease are further discussed in “Pathophysiology and genetics of Parkinson's Disease”. Not all atypical Parkinsonism are easy to diagnose. In fact, understanding of genetically determined conditions such as fragile X ataxia tremor syndrome and other atypical, atypical Parkinsonism is useful to get to the correct diagnosis in difficult clinical situations. These conditions are discussed in “Atypical Atypical Parkinsonism”.
 
HISTORY AND PRESENTING COMPLAINTS
 
Impairments in Physical Functions
Bradykinesia or slowness of movement is the hallmark of Parkinson's disease. The fluency, coordination, efficiency, and speed of composite, and fine motor movements are usually diminished early in the disease course. This may manifest as difficulty with doing buttons, shoe laces, putting on a bra, or jewelry hooks. Sometimes, the signs appear earlier if a person's occupation or hobbies require manual dexterity and speed like catching a ball. A dancer may fail to keep up with the beat, a pianist or a musician may slow down the tempo, or a typist may get slower with the tasks. Difficulty due to slowness in getting in and out of a car or slowness when standing up after prolonged sitting on floor for prayers or assemblies may be a very early sign.
The resting tremor of Parkinson's disease is usually a slow tremor which is brought on at rest or with mental distraction (like when watching television or walking). Tremor usually is easy to detect, but often patients tend to ignore it, specifically if the tremor is at rest. In the early stages, tremor may be easy to suppress by simply moving the hand. The patients also tend to hide the tremor while walking by putting the hand in the pocket.
If the tremor is mainly postural, the symptoms may be more distressing. The patients may have difficulty using knife and forks. Spilling peas while eating, spilling a drink while pouring, and often asking for help at dinner table is common. Parkinson's disease patients with tremor additionally lack manual dexterity which makes fine hand movements almost impossible. A significant postural tremor interferes with eating, dressing, grooming, handwriting, hobbies, and tasks, and challenges the functional independence. Handwriting deteriorates commonly with 4words becoming progressively smaller as the person continues to write. While taking history, it is worth knowing the side dominance and handedness, as one generally relies on one hand more than the other for most tasks.
A combination of tremor, bradykinesia, and loss of dexterity lead to an inability in carrying out actions requiring fine motor skills, such as handling fasteners; actions requiring larger alternating or rotating movements, such as buttering and cutting bread, washing hair, and brushing teeth; and actions requiring balance, such as clothing the lower part of the body and bending over or reaching to get things out of a closet or cabinet. In addition, mental and physical fatigue and reduced stamina make it difficult to sustain activities.
Gait impairment and falls are the most dreaded complications related to Parkinson's disease. The gait impairment relates to disease progression in Parkinson's disease. Very early unprovoked falls (within 1 year) should make one suspicious feature of the diagnosis of Parkinson's disease as this is an atypical feature seen in PSP. Early falls may be related to postural hypotension which may be drug induced in cases with Parkinson's disease or may reflect the underlying diagnosis of MSA.1,2
Studies examining the risk factors for falling associated with Parkinson's disease indicate that problems with stability, transfers, walking (e.g., freezing, propulsion), and orthostatic hypotension play a primary role.3 Freezing is a common problem where feet seem unable to move as if frozen to the floor. Freezing mainly occurs when starting to walk, passing through close spaces, or large open spaces, turning or performing multiple tasks while walking.4 Based on these situations, the subtypes of freezing include: start hesitation, turn hesitation, hesitation in tight quarters, destination hesitation, and open space hesitation. Freezing is a common cause of falls. This is more common when patients have difficulty performing the transfer with sufficient speed, and usually do not bring their torsos forward enough and may fall.
Camptocormia or extreme flexed, or tilted posturing of the spine can mechanically affect walking and predispose to forward falls. The basis of camptocormia is poorly understood but it seems that there is initially an increased tone which is followed by muscle wasting and weakness later. Although craniocervical dystonia, such as blepharospasm or cervical torticollis may be seen with Parkinson's disease, anterocollis or forward flexion of neck is more suggestive of MSA.
Independent living in patients with Parkinsonism is challenged mainly by gait and balance impairment but tremor, bradykinesia (slowness of movement), dystonia, and dyskinesia (dopamine treatment induced) can also be very limiting.5 The drug-induced dyskinesia is generally choreiform. Dyskinesias are the most common long-term complication in Parkinson's disease and can be seen in almost half of all the patients after 10 years of treatment. The dyskinesia can affect speech, swallowing, posture, and gait.
Dystonia can manifest with abnormal postures which are mobile (neither are these postures fixed nor are they like contractures) and vary from time to time based on action (action dystonia) or task (task specific dystonia). Dystonia can be seen in Parkinson's disease in many forms. Blepharospasm manifests with increased blinking and closed eyes which are difficult to open spontaneously. If severe, this can lead to partial blindness. Foot dystonia is much more common in the early morning. Foot dystonia may become prominent on walking specially in off periods of 5Parkinson's disease when the medication is wearing off. Hand dystonia can present as a permanently closed hand which can be opened passively (unlike contractures). This posturing impairs the hygiene of the hands and can lead to multiple skin infections of the creases of the palm. In general, patients with Parkinson's disease get dystonia in off periods and dyskinesia as a peak dose effect with dopamine, but this is not a rule. Persistent and severe dystonia in one hand with or without an alien limb phenomenon should alert the physician to the possibility of CBD.
 
Impairments in Mental Functions
The pathophysiology of parkinsonism is quite complex and affects the performance of complex, well-learned movements, as well as executive function.6 This interferes with most activities of daily living that involve automatic or subconscious preplanning, initiation, and sequencing of movements. Early cognitive impairment with dementia, autonomic involvement, and hallucinations must alert one to the possibility of Lewy body dementia or DLB (see chapter on dementia with lewy body disease). Significant aphasia or apraxia can reflect cortical dysfunction which can be seen in CBD (see chapter corticobasal degeneration). Frontal executive dysfunction and disinhibition are commonly seen in PSP. There are several signs of PSP that are linked to this frontal subcortical involvement (see chapter clinical approach to progressive supranuclear palsy) like the applause sign.
 
Nonmotor Impairments
Sometimes, nonmotor features including anxiety, depression, psychosis (hallucinations), nocturia, constipation, and sleep problems can have a greater bearing on the quality of life than motor symptoms.
  • Sensory symptoms: Anosmia and pain can be important non-motor symptoms. There can be several types of pain associated with Parkinson's disease (musculoskeletal, dystonic, radicular, central, and akathisia) and it is important to discern the root cause to offer effective intervention
  • Speech and swallowing may also be affected, particularly as the condition progresses.7 Communication is less supported by nonverbal expression and gestures. Writing is affected by progressive micrographia.8 Taste may be affected and loss of smell is an early sign of Parkinson's disease. These factors may contribute to disinterest in food and weight loss
  • Drooling or sialorrhoea can be very embarrassing and precludes a large amount of social interaction and contributes to social segregation in patients with Parkinson's disease. Drooling in Parkinson's disease is largely the result of swallowing difficulties rather than excessive saliva production. Although management strategies are often focussed on reducing saliva production (see chapter on nonmotor symptoms management)
  • Sleep is commonly affected and rapid eye movement sleep behavior disorder may be the first sign of Parkinson's disease. Excessive daytime sleepiness is common and often due to treatable causes like obstructive sleep apnea syndrome or a side effect of medication. Other nocturnal disturbances include difficulty in turning in bed, vivid dreams, motor fluctuations, and nocturia6
    zoom view
    FLOWCHART 2: Specific features may occur with individual varieties of atypical Parkinsonism
  • Breathing difficulties are uncommon apart from obstructive sleep apnea, but if inspiratory sigh or stridor is present, MSA should be considered
  • Neuropsychiatric features include dopamine dysregulation syndrome, commonly due to dopamine agonists and dopamine dependence. Hallucinations may be a sign of drug induced psychosis, or DLB.
As indicated in flowchart 2, specific features may occur with individual varieties of atypical Parkinsonism. Progressive supranuclear palsy is associated with early falls, limitation of eye movements, cognitive decline, and dysarthria9 (see chapter on PSP). Multiple system atrophy is often complicated by early and severe postural hypotension, urinary incontinence, and anterocollis of neck, dysarthria, and sometimes cerebellar ataxia10 (see chapter on multiple system atrophy). Dementia with Lewy bodies is associated with severe hallucinations, cognitive decline, bladder dysfunction, and postural hypotension (see chapter on dementia with lewy body disease). Corticobasal degeneration is complicated by concurrent myoclonus, dystonia, and apraxia of limb (see chapter on corticobasal degeneration). Alien limb phenomenon which is unique in this condition can be refractory to all current treatment strategies and with apraxia, it can make one hand entirely useless and autonomous. This phenomenon is very rare in practice.
 
Other Clinical Features that Help Differentials
Strokes and vascular changes can present with features similar to Parkinson's disease. Normal pressure hydrocephalus (NPH) may have gait problems similar to Parkinson's disease with cognitive impairment and urinary incontinence. One must be careful in eliciting history of vascular risk factors. Trauma and subdural hematoma (SDH) may present with Parkinsonism. Exposure to toxins and drugs must be excluded and a family history of Parkinson's disease or tremor may be useful. Some conditions may superficially resemble Parkinson's disease but have a different heredodegenerative basis like the Westphal variant of Huntington's disease, Wilson's disease, spinocerebellar ataxias with Parkinsonism, neurodegeneration with brain iron accumulation, and primary familial brain calcification. Some of these conditions are discussed elsewhere in this book.7
 
EXAMINING A PATIENT WITH SUSPECTED PARKINSON'S DISEASE
 
Gait
The gait of a patient with Parkinson's disease can be a very important sign. Usually, observing a patient walking in the clinic with a slow shuffling gait, slightly bent forward posture, and reduced arm swing with tremor in one hand is almost pictorial. One may have to observe more closely to pick up changes such as mild dystonia or dragging of one leg, or subtle features of freezing especially while passing doorways. It is always useful to observe the stride length and lift from the ground, both of which are reduced in Parkinson's disease. Festination is the tendency to walk faster with small steps, as if trying to catch the center of gravity to prevent a fall. Freezing commonly presents with the feet being stuck to the floor. It is slightly different and more prolonged than start hesitation and can happen when approaching narrow paths or when the landscape of the road or path is changing. Standing behind the patient and giving them a gentle tug backwards to displace their balance can be a good test (called pull test) for postural instability. Normally a person should be able to resist the pull or take up to 2 corrective steps backwards, but a patient with Parkinsonism will tend to fall or take more than 2 steps. Postural instability might be earlier in onset in atypical Parkinsonism such as PSP where falls and postural instability can appear within the first year.
 
Tremor
The best way to examine a patient for resting tremor is asking them to sit with their hands completely relaxed in their lap (distracting them with conversation can help) or while walking. If the tremor has the classic pill rolling character (as if rolling a pill or a rosary bead between the finger and thumb), it is almost diagnostic of Parkinson's disease. The commonest differential for Parkinson's disease tremor are essential tremor and dystonic tremor.11
Postural tremor can be seen in Parkinson's disease but there is often a slight pause after moving the hand from a resting state with tremor, before the tremor re-emerges as a postural tremor. This re-emergent tremor is almost characteristic of Parkinson's disease.
The other features that distinguish the different varieties of tremors are listed in table 2. The cerebellar tremors usually have past pointing and dysdiadochokinesia. The functional tremor can be very difficult to distinguish and there can be a presentation that mimics functional Parkinsonism. Specifically, the tremor is very variable and can vary in being side to side at sometimes and up and down on others. The amplitude can also vary. These tremors are distractible and get better when the patient is asked to do some mental tasks like arithmetic or physical tasks such as alternating finger movements with the other hand. It may be possible to train the frequency of functional tremor by tapping one hand at a certain speed the tremor takes on the speed of the taps. These phenomenon, variability, distraction, and entrainability help with the diagnosis of functional tremor.12 It is worth noting that patients with atypical Parkinsonism such as PSP and corticobasal syndrome do not 8have the rest tremor, however, MSA and DLB can look very similar to Parkinson's disease with respect to the tremor in the early stages. Myoclonus with tremor can be seen in MSA.
TABLE 2   Features helping with differential diagnosis of Parkinson's disease tremor
Tremor of Parkinson's disease
Essential tremor
Dystonic tremor
Cerebellar tremor
Functional tremor
Rest/action/posture
Worst at rest, disappears on action reemergent on posture after a small pause
Worst on posture, absent at rest
Worst on posture, tasks maybe present at rest
Worst on action, not at rest, may happen on some postures
Variable
Intention tremor
No
Maybe
No
Yes
No
Frequency
4–6 Hz
5–10 Hz
Variable and jerky
Variable
Variable
Family history
Uncommon
Yes
Maybe
Maybe in spinocerebellar ataxia
No
Alcohol
No effect
Makes better
No effect or partial effect
Makes worse
No effect
Other features
Anosmia Bradykinesia Cogwheel rigidity
None or Mild cerebellar features
Associated abnormal postures like cervical or limb dystonia
Ataxic gait, dysarthria, nystagmus
Distractability and entrainability*
Imaging characteristics
DaTscan—reduced striatonigral uptake
Normal
Normal
Normal or cerebellar atrophy/lesion
Normal
Treatment
Dopaminergic treatment
Trihexyphenidyl
Propranolol
Propranolol, trihexyphenidyl, botulinum toxin
None
Multidisciplinary
SCAs, spinocerebellar ataxia.
*see text for description.
 
Bradykinesia
Finger and foot taps are the most crucial part of examination of a patient with suspected Parkinson's disease. There is slowness with a decremental response that helps identify “true” bradykinesia. Whole body bradykinesia may be identified by reduced overall movements and some other signs include drooling (due to bradykinesia of swallow) and reduced blink rate. False bradykinesia can be seen with corticospinal involvement which is associated with weakness and corticospinal features.9
 
Rigidity
The rigidity of Parkinsonism is best appreciated distally at wrist and elbow with slow movements (contrary to fast velocity for spasticity). The classic cogwheel rigidity is commonly asymmetric with it being more on one side. Striatal extension of toe is a useful sign of Parkinsonism. Axial rigidity may be more than limb rigidity in atypical Parkinsonism and akinetic rigid variety of Parkinson's disease.
 
Ocular Features
Eye movements should be normal on bedside examination in Parkinson's disease and MSA. Supranuclear gaze palsy can be seen in PSP and tested by looking for saccades, pursuit, and range of movement. The saccades are slow, pursuits are broken, and vertical gaze restriction is seen in PSP. Corticobasal syndrome may have slow initiation of saccades with mild restriction of gaze.
 
Dysarthria and Lower Cranial Nerves
Parkinson's disease patients characteristically have dysarthria with decreased volume, slow articulation, faster or slower speech rate and a monotone, high pitch voice.13 Growling dysarthria is seen in PSP and low volume quivery dysarthria has been described in MSA.14 Swallowing may be impaired in Parkinson's disease but early involvement of swallowing due to pseudobulbar palsy is seen in patients with PSP.
Table 3 summarizes the essentials of neurological examination in a patient with suspected Parkinson's disease.
TABLE 3   Examination of a patient with suspected Parkinson's disease
Cranial nerves
Motor system
  • Olfactory
  • Ocular movements
    • Saccades
    • Pursuits
    • Range of movements
    • Nystagmus
    • Blepharospasm or apraxia of lid opening
  • Lower cranial nerves
    • Dysarthria
    • Pseudobulbar palsy
  • Pyramidal signs
    • Tone, reflexes, plantar response
    • Weakness
  • Extrapyramidal signs
    • Tremor-rest, posture, action, intention
    • Cogwheeling
    • Finger taps, foot taps, repetitive tongue movements for bradykinesia
  • Cerebellar
    • Finger nose test
    • Dysdiadochokinesia
    • Tandem walking
  • Gait
    • Arm swing
    • Cadence, speed, steps
    • Festination
    • Freezing
10
 
Neurological Examination
Corticospinal features are not expected in a case with Parkinson's disease and if present one must look for evidence of strokes, cervical myelopathy, subdural hematoma, or suspect MSA. Similarly, presence of cerebellar signs should alert one for the possibility of MSA or stroke.
 
Diagnosing Parkinson's Disease
The diagnostic criteria for Parkinson's disease are derived from a large pathological series15 but the rate of diagnosis can vary. The National Institute of Neurological Disorders and Stroke diagnostic criteria are included in Box 2 and UK Parkinson's Disease Brain Bank criteria in flowchart 3.
11
zoom view
FLOWCHART 3: Parkinson's disease UK Brain bank criteria for diagnosis of Parkinson's disease
There are several rating scales used in assessment of Parkinson's disease.16 The appendix contains the Movement Disorder Society Unified Parkinson's Disease Rating Scale and Non-Motor Scale questionnaire, the most accepted questionnaires used in assessment.
 
Differential Diagnosis of Parkinsonism
Table 4 summarizes the clinical features in Parkinsonism.
 
INVESTIGATIONS
Usually the blood tests, and brain imaging are normal in Parkinson's disease. There is a strong argument that the diagnosis is purely clinical and sometimes in clinical settings one can avoid any investigations and start treatment for the patient with Parkinson's disease. However, some clinical scenarios require excluding other causes. Blood tests are helpful to exclude Wilson's disease and in people less than 50 years, urinary copper and serum caeruloplasmin are indicated. Computed tomography scan or magnetic resonance imaging of brain can help exclude NPH, SDH, Stroke affecting the basal ganglia, and other lesions that can present with Parkinson's disease like presentation. Neuroimaging can also help identify calcium, iron, or manganese deposition that can be linked to Parkinsonism. In atypical Parkinsonism, characteristic midbrain atrophy in PSP or hot cross bun sign in MSA are almost diagnostic. Posterior rim of iron in putamen can help diagnose MSA. Face of giant Panda in Wilsons’ or caudate atrophy in Huntington disease can also suggest alternative diagnosis.
Nuclear imaging with DaTscan can be very helpful when distinguishing Parkinson's disease from other causes of tremor. Metaiodobenzylguanidine scan is specifically abnormal in Parkinson's disease and can help differentiate Parkinson's disease from atypical parkinsonism. Details of neuroimaging are discussed in chapter “Nuclear imaging in Parkinsonism”12
TABLE 4   Examination aid to diagnosis of Parkinsonism
PSP
MSA
CBS
PD
DLB
Higher mental function
  • Frontal signs- (Applause sign, disinhibition, impaired Luria test
  • Normal
  • Aphasia
  • Apraxia
  • Frontotemporal signs
  • Normal
  • Dementia with fluctuating cognition
  • Hallucination
  • Delirium common
Cranial Nerves
  • Restricted vertical gaze
  • Slow saccades (Vertical > horizontal)
  • Broken pursuit
  • Apraxia of lid opening
  • Pseudobulbar palsy
  • Growling dysarthria
  • Cerebellar ocular signs or normal eye movement
  • Quivery dysarthria
  • Facial dyskinesia (often dopamine induced)
  • Slow saccades (horizontal > vertical)
  • Broken pursuit
  • Normal except anosmia
  • Variable ocular involvement
Motor system
  • Axial rigidity
  • No tremor
  • Axial rigidity
  • Postural or myoclonic tremor
  • Brisk reflexes
  • Babinski response
  • Limb dystonia
  • Asymmetry
  • No tremor
  • Myoclonus
  • Pill rolling tremor with reemergence on posture
  • Cogwheel rigidity
  • Asymmetry
  • Axial rigidity
  • Postural or rest tremor
  • Asymmetry
Gait
  • Poor recovery on pull test and falls
  • Prominent freezing
  • Poor recovery on pull test and falls
  • Poor recovery on pull test and falls
  • Poor recovery on pull test
  • Gait festination
  • Poor recovery on pull test
  • Gait festination
Autonomic signs
  • Neurogenic bladder (urge incontinence)
  • Erectile dysfunction
  • Orthostatic hypotension
  • Neurogenic bladder (urge incontinence)
  • Erectile dysfunction
  • Orthostatic hypotension
PSP, progressive supranuclear palsy; MSA, multiple system atrophy; CBS, corticobasal syndrome; PD, Parkinson's Disease; DLB, dementia with Lewy bodies.
13
 
CONCLUSION
Parkinsonism is characterized by bradykinesia, with additional features of tremor, postural instability, and rigidity. The diagnosis of Parkinson's disease is clinical and a typical patient with early Parkinson's disease may have asymmetric bradykinesia, rest tremor, and cogwheel rigidity with mild postural imbalance. A careful history and examination, standardized diagnostic criteria, and monitoring scales at the initial and each follow-up visit can help manage nonmotor features, monitor progression and response to treatment, and help identify unusual features to suggest atypical parkinsonism or an alternative diagnosis. Investigations are not always needed but can be supportive of a clinical diagnosis of Parkinson's disease.
REFERENCES
  1. Klein C, Wenning GK, Quinn NP. Pseudotransitory ischemic attacks as the initial symptom of multiple system atrophy. Der Nervenarzt. 1995;66(2):133–5.
  1. Kollensperger M, Geser F, Seppi K, et al. Red flags for multiple system atrophy. Mov Disord. 2008;23(8):1093–9.
  1. Grimbergen YA, Munneke M, Bloem BR. Falls in Parkinson's disease. Curr Opin Neurol. 2004;17(4):405–15.
  1. Fahn S. The freezing phenomenon in parkinsonism. Advances in neurology. 1995;67:53–63.
  1. Jankovic J, Kapadia AS. Functional decline in Parkinson disease. Archives of neurology. 2001;58(10):1611–5.
  1. Aarsland D, Bronnick K, Ehrt U, et al. Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry. 2007;78(1):36–42.
  1. Pinto S, Ozsancak C, Tripoliti E, et al. Treatments for dysarthria in Parkinson's disease. Lancet Neurol. 2004;3(9):547–56.
  1. Wagle Shukla A, Ounpraseuth S, Okun MS, et al. Micrographia and related deficits in Parkinson's disease: a cross-sectional study. BMJ Open. 2012;2(3).
  1. Litvan I, Lees AJ. Progressive supranuclear palsy. Adv Neurol. 1999;80:341–5.
  1. Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sciences. 1999;163(1):94–8.
  1. Erro R, Rubio-Agusti I, Saifee TA, et al. Rest and other types of tremor in adult-onset primary dystonia. J Neurol Neurosurg Psychiatry. 2014;85(9):965–8.
  1. Edwards MJ, Bhatia KP. Functional (psychogenic) movement disorders: merging mind and brain. Lancet Neurol. 2012;11(3):250–60.
  1. Sapir S, Ramig L, Fox C. Speech and swallowing disorders in Parkinson disease. Curr Opin Otolaryngol Head Neck Surg. 2008;16(3):205–10.
  1. Quinn NP, Wenning GK. Multiple system atrophy. AdvNeurol. 1996;69:413–9.
  1. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55(3):181–4.
  1. Ebersbach G, Baas H, Csoti I, et al. Scales in Parkinson's disease. J Neurol. 2006;253 Suppl 4:IV32–5.